Harry P. Selker, MD, MSPH

“We help researchers from all backgrounds to develop new methods and translate discoveries into practice, break down the barriers that slow the process of determining the effectiveness of those methods, and work together to bring about change that improves human health.”

Harry P. Selker, MD, MSPH
Tufts CTSI Dean and Principal Investigator

Overview

Tufts CTSI was established in 2008 with a Clinical and Translational Science Award (CTSA) from the National Institutes of Health (NIH). We are one of more than 50 institutions comprising the national CTSA Consortium, led by the National Center for Advancing Translational Sciences, part of NIH.

During our first award, we built a robust partnership of 39 organizations and developed a unique identity within the CTSA Consortium, with nationally recognized strengths in emergency medicine, large effectiveness trials, clinical trials methods innovations, and translational science education.

In 2013, we were recognized as a translational science leader by NIH when we were awarded a second CTSA. This major accomplishment allows us to continue to provide extensive services, resources, education, and mentorship to investigators across the partnership.

We were awarded a third CTSA in 2018.

From bench to bedside, to clinical practice, to care delivery and public health, to public policy and beyond, Tufts CTSI is committed to fostering collaboration and innovation across the translational spectrum.

The Aims of our Third NIH CTSA Grant

Aim 1

Create an environment, resources, and services to stimulate and support the full spectrum of clinical and translational research (CTR) by leveraging the diverse expertise and assets of Tufts CTSI partners.

Aim 2

Cultivate broadly-engaged team science, actively including stakeholders, to promote relevant and impactful translation for diverse populations and across the lifespan.

Aim 3

Develop, demonstrate, and disseminate innovations in methods, research process improvement, and evaluation, to advance CTR locally and nationally.

Aim 4

Advance methods and performance of multi-site clinical trials within the Tufts CTSI Clinical Research Network, the NCATS Trial Innovation Network, and in other multi-institutional networks.
Aim 5. Provide outstanding education, training, and mentoring, tailored to different roles and disciplines, to advance a diverse CTR workforce, and share these resources nationally.